Immunophenotyping of human tumor-reactive T cell functionality using flow cytometry
MBTP 61 = Miltenyi Biotec-tested panel 61
This application protocol describes the analysis of human tumor-reactive T cell functionality by detection of intracellular and extracellular markers. To demonstrate the state-of-the-art panel, tumor-infiltrating leukocytes (TILs) were isolated from a human melanoma digest. The contained tumor-reactive T cells (TRTs) were enriched using CD137 MicroBeads and expanded for two weeks using the CliniMACS Prodigy®. For functionality testing, TRTs were then co-cultured with autologous or mismatched tumor cell lines in presence of a protein transport inhibitor containing monensin and brefeldin A. TRTs were subsequently analyzed by flow cytometry to determine their anti-tumor reactivity in terms of T cell degranulation (CD107a/LAMP-1), T cell activation (CD154, CD137), and production of inflammatory cytokines (IFNγ, TNFα).
You have previously chosen International as your location.
What do you want to do?